TGA Approval

ELAPRASE idursulfase-rhu solution for IV infusion vial (129481)

ARTG ID

129481

ARTG Name

ELAPRASE idursulfase-rhu solution for IV infusion vial

Sponsor

Sanofi-Aventis Australia Pty Ltd

ARTG Date

February 21, 2008

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

SANOFI-AVENTIS AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/b41ed4531af21381c480bba60f633d45.pdf

https://medical-cdn.nocode.com/drug_tga/38e1e16a023d95b553f18c933466f1a6.pdf

Ingredient Name

Idursulfase

Empowering clinical research with data-driven insights and AI-powered tools.

ELAPRASE idursulfase-rhu solution for IV infusion vial (129481) - TGA 批准文号 | MedPath